Gene therapy: Principles, risks and perspectives in hepatogastroenterology;La therapie genique: Principes, enjeux et perspectives en hepato-gastroenterologie

Hepato-Gastro

Volumn 4, Issue 2 SUPPL., 1997, Pages 110-119

  Bralet, Marie Pierre ^a   Duisit, Ghislaine ^b   Dupas, Benoît ^b   Moullier, Philippe ^b   Ferry, Nicolas ^c  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c CENTRE EUGÈNE MARQUIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

CANCER RESEARCH; CLINICAL PROTOCOL; CONFERENCE PAPER; GENE THERAPY; GENE TRANSFER; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK BENEFIT ANALYSIS;

EID: 0030930977     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Kahn A. Thérapie génique, l'ADN médicament John Libbey Eurotext, France 1993.
2. Orkin S, Motuslky A. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. NIH 1995. World Wide Web : http/ /www.nih.gov/news/panelrep.html., 1-49.
3. Bralet M, Branchereau S, Brechof C, Ferry N. Cell lineage study in me liver using retroviral mediated gene transfer - Evidence against the streaming of hepatocytes in normal liver. Am J Pathol 1994 ; 144 : 896-905.
4. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Andersen WF, et al Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993 ; 341 : 85-6.
5. Mulligan RC The basic science of gene therapy Science 1993 ; 260 : 926-32.
6. Arbuthnot P, Bralet M, Le Jossic C, Dedieu J, Perricaudet M, Bréchot C, et al. In vitro and in vivo hepatoma cell specific expression of a gene transferred with an adenoviral vector. Hum Gene Ther 1996 ; 7 1503-14
7. Crystal RG. Transfer of gene to humans : early lessons and obstacles to success. Science 1995 ; 270 : 404-10.
8. Arbuthnot P, Bralet M, Thomassin H, Danan J, Brechot C, Ferry N. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-feto-protein but not insulin-like growth factor II regulatory sequences Hepotology 1995 ; 22 : 1788-96.
9. Moullier P, Bohl D, Heard JM, Danos O. Correction of lysosomal storage in the liver and spleen of genetically-modified skin fibroblasts. Nature Genetique 1993 ; 4 : 154-9.
10. Moullier P, Bohl D, Cardoso J, Heard JM, Danos O. Long term delivery of a lysosomal enzyme by genetically-modified fibroblasts in dogs. Nature Medicine 1995 ; 1 : 353-7
11. Cohen-Haguenauer O. Overview of regulation of gene therapy in Europe a current statement including reference to US regulation. Hum Gene Ther 1995 ; 6 : 773-85.
12. Lau C, Soriano H, Ledley F, Finegold M, Wolfe J, Birkenmeier E, Henning S Retroviral gene transfer into the intestinal epithelium Hum Gene Ther 1995 ; 6 : 1145-51
13. Schmid RM, Weidenbach H, Draenert GF, Lerch MM, Liptay S, Schorr J, et al. Liposome mediated in vivo gene transfer into different tissues of the gastrointestinal tract. Zeitschrift fur Gastroenterologie 1994 ; 32 : 665-70.
14. Jones S, Grompe M, Munir M, Veres G, Craigen W, Caskey C. Ectopic correction of ornithine transcarbamylase deficiency in sparse fur mice. J Biol Chem 1990 ; 265 : 14684-90.
15. Ferry N, Duplessis O, Houssin D, Danos O, Heard JM. Retroviral-mediated gene transfer into hepatocytes in vivo Proc Natl Acad Sci USA 1991 ; 88 : 8377-81.
16. Stratford-Perricaudet LD, Levrero M, Chasse JF, Perricaudet M, Briand P. Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector. Hum Gene Ther 1990 ; 1 : 241-56.
17. Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SLC. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum Gene Ther 1993 ; 4 : 403-9.
18. Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczöl E, Wilson JM Cellular immunity to viral antigens limits El-deleted adenovi ruses for gene therapy Proc Natl Acad Sci USA 1994, 91 4407-11.
19. Bralet M, Calise D, Brechot C, Ferry N. In vivo cell lineage analysis during chemical hepatocarcinogenesis using retroviralmediated gene transfer. Lab Invest 1996 ; 74 : 871-81.
20. Zajicek G, Oren R, Weinreb M The streaming liver. Liver 1985 ; 5 : 293-300.
21. Chang A, Wu G. Gene Therapy - Applications to the treatment of gastrointestinal and liver diseases. Gastroenterology 1994 ; 106 : 1076-84.
22. Kay M, Woo S. Gene therapy for metabolic disorders. Trends Genet 1994 ; 10 253-7
23. Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia Nature Genetique 1994 ; 6 : 335-41.
24. Raper S, Grossman M, Rader D, Thoene J, Clark B, Kolansky D, et al. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg 1996; 223 . 116-26.
25. Mouiller P, Maréchal V, Danos O, Heard JM. Continous systemic secretion of a lysosomal enzyme by genetically-modified mouse skin fibroblasts Transplantation 1993 , 56 : 427-32.
26. Teckman J, Perlmutter D. Conceptuel advances in the pathogenesis and treatment of childhood metabolic liver disease. Gastroenterology 1995 , 108 : 1263-79.
27. Lieber A, Kay M. Adenovirus-mediated expression of ribozymes in mice. J Virol 1996 ; 70 : 3153-8.
28. Nakazono K, Ito Y, Wu C, Wu G. Inhibition of hepatitis B virus replication by targeted pretreatmenf of complexed antisense DNA in vitro. Hepatology 1996 ; 23 : 1297-303.
29. Roth J, Nguyen D, Lawrence D, Kemp B, Carrasco C, Ferson D, et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med 1996, 2 : 985-91.
30. Boo J, Zhang W, Kuo M Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas. Hum Gene Ther 1996 ; 7 . 355-65.
31. Pardoll D Cancer Vaccines, Immunol Today 1993 ; 14 : 310-6.
32. Freeman S, Abboud CN, Whartenby KA, Pakman CH, Koeplin DS, Moolten FL, Abraham GN : the « bystander effect » : tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993 , 53 . 5274-83.
33. Caruso M, Panis Y, Gagandeep S, Didier H, Salzmann JL, Klatzmann D. Regression of established macroscopic liver metastases after in situ tranduction of a suicide gene. Proc Natl Acad Sci USA 1993 , 90: 7024-8.
34. Marcel T, David Grausz J The TMC worldwide gene therapy enrollment report. Hum Gene Ther 1996 ; 7 : 2025-46
35. Lan KH, Kanai F, Shiratori Y, Okabe S, Yoshida Y, Wakimoto H, et al. Tumor-specific gene expression in corcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors Gastroenterology 1996 ; 111 : 1241-51.